Skip to main
AVTX
AVTX logo

Avalo Therapeutics (AVTX) Market Capitalization Overview

Market Cap: $52.41M as of Jun 13, 2025

$52.41M
Past Month+$10.62M (25.39%)
As of Jun 13, 2025, Avalo Therapeutics (AVTX) has a market capitalization of $52.41M. Over the past 30 days, its market cap has decreased by -12.43%, while in the last 12 months, it has decreased by -32.59%.

Market capitalization represents the total value of Avalo Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Avalo Therapeutics (AVTX) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Avalo Therapeutics (AVTX) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Avalo Therapeutics (AVTX) Market Cap History

DateMarket CapChange
Jun 2, 2025$47.11M-12.43%
May 1, 2025$53.79M-26.42%
Apr 1, 2025$73.11M+4.27%
Mar 3, 2025$70.11M-16.46%
Feb 3, 2025$83.92M-4.86%
Jan 2, 2025$88.21M-14.42%

Avalo Therapeutics (AVTX) End of Year Market Cap History

DateMarket CapChange
2025$52.41M-32.59%
2024$77.75M+965.80%
2023$7.30M-84.63%
2022$47.45M-75.26%
2021$191.76M-3.16%
2020$198.02M

FAQs About Avalo Therapeutics (AVTX) Market Cap

As of Jun 13, 2025, the market capitalization of Avalo Therapeutics (AVTX) is $52.41M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Avalo Therapeutics’s market capitalization has increased by 25.39%, changing from $41.80M to $52.41M as of Jun 13, 2025.

In the last 3 months, Avalo Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Avalo Therapeutics’s market capitalization increased from $7.30M in January to $77.75M in December, reflecting a 965.8% change.

In the past five years, Avalo Therapeutics (AVTX) has had a compound annual growth rate (CAGR) of -17.05% in market capitalization. This means its market cap has shrunk at an average rate of -17.05% per year.

Avalo Therapeutics (AVTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.